SMAD2 and diabetic kidney disease: In another study, inhibition of latent TGFβ1-TSP1 interaction with a specific peptide attenuated DKD in type 1 diabetic Akita mice, with a reduction in proteinuria, urinary active TGFβ1 and Smad2/3 activation.